Activation of Vγ9Vδ2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication

International Immunology

Volumn 18, Issue 1, 2006, Pages 11-18

  Agrati, Chiara ^a   Alonzi, Tonino ^a   De Santis, Rafaella ^a   Castilletti, Concetta ^a   Abbate, Isabella ^a   Capobianchi, Maria Rosaria ^a   D'Offizi, Gianpiero ^a   Siepi, Francesca ^a   Fimia, Gian Maria ^a   Tripodi, Marco ^a,b   Poccia, Fabrizio ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

T cells; Hepatitis C; IFN ; Natural immunity

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; PEPTIDE DERIVATIVE; PHOSPHOSTIM; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA; ZOLEDRONIC ACID; ANTIGEN; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SYNTHESIS; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; T LYMPHOCYTE ACTIVATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; CELL LINE; COCULTURE; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; TH1 CELL;

ANTIGENS; BONE DENSITY CONSERVATION AGENTS; CELL LINE; COCULTURE TECHNIQUES; DIPHOSPHONATES; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMIDAZOLES; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA, VIRAL; TH1 CELLS; VIRUS REPLICATION;

EID: 30344451987     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh337     Document Type: Article

References (39)

1. Lauer, G. M. and Walker, B. D. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41.
2. Ippolito, G. and Craxi, A. 2003. Hepatitis C: Virus, host, disease. Cell Death Differ. 10(Suppl. 1):S1.
3. Capobianchi, M. R., Abbate, I., Cappiello, G. and Solmone, M. 2003. HCV and interferon: Viral strategies for evading innate defence mechanisms in the virus-host battle. Cell Death Differ. 10(Suppl. 1):S22.
4. Willberg, C., Barnes, E. and Klenerman, P. 2003. HCV immunology - death and the maiden T cell. Cell Death Differ. 10(Suppl. 1): S39.
5. Poccia, F. and Agrati, C. 2003. Intrahepatic natural immunity and HCV immunopathogenesis. Cell Death Differ. 10(Suppl. 1):S9.
6. Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R. and Chisari, F. V. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825.
7. Liu, C., Zhu, H., Tu, Z., Xu, Y. L. and Nelson, D. R. 2003. CD8+ T-cell interaction with HCV replicon cells: Evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 37:1335.
8. Poccia, F., Agrati, C., Martini, F., Capobianchi, M. R., Wallace, M. and Malkovsky, M. 2005. Antiviral reactivities of γδ T cells. Microbes Infect. 7:518.
9. Yonekura, K., Ichida, T., Sato, K. et al. 2000. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 20:357.
10. Par, G., Rukavina, D., Podack, E. R. et al. 2002. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J. Hepatol. 37:514.
11. Constant, P., Davodeau, F., Peyrat, M. A. et al. 1994. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267.
12. Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B. and Bloom, B. R. 1995. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375:155.
13. Tanaka, Y., Brenner, M. B., Bloom, B. R. and Morita, C. T. 1996. Recognition of nonpeptide antigens by T cells. J. Mol. Med. 74:223.
14. Espinosa, E., Belmant, C., Pont, F. et al. 2001. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells. J. Biol. Chem. 276: 18337.
15. Bukowski, J. F., Morita, C. T. and Brenner, M. B. 1999. Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity. Immunity 11:57.
16. Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H. P. and Wilhelm, M. 2000. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384.
17. Kunzmann, V., Bauer, E. and Wilhelm, M. 1999. Gamma/delta T-cell stimulation by pamidronate. N. Engl. J. Med. 340:737.
18. Li, E. C. and Davis, L. E. 2003. Zoledronic acid: A new parenteral bisphosphonate. Clin. Ther. 25:2669.
19. Wilhelm, M., Kunzmann, V., Eckstein, S. et al. 2003. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 102:200.
20. Viey, E., Fromont, G., Escudier, B. et al. 2005. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174:1338.
21. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. and Bartenschlager, R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110.
22. Blight, K. J., Kolykhalov, A. A. and Rice, C. M. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972.
23. Fimia, G. M., Evangelisti, C., Alonzi, T. et al. 2004. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation. J. Virol. 78:12809.
24. Murray, E. M., Grobler, J. A., Markel, E. J. et al. 2003. Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. J. Virol. 77:2928.
25. Frese, M., Schwarzle, V., Barth, K. et al. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694.
26. Guo, J. T., Bichko, V. V. and Seeger, C. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516.
27. Battistini, L., Borsellino, G., Sawicki, G. et al. 1997. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J. Immunol. 159:3723.
28. Capobianchi, M. R., Ameglio, F., Cordiali, F. P. et al. 1993. Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. AIDS Res. Hum. Retrovir. 9:957.
29. Wallace, M., Bartz, S. R., Chang, W. L., Mackenzie, D. A., Pauza, C. D. and Malkovsky, M. 1996. Gamma delta T lymphocyte responses to HIV. Clin. Exp. Immunol. 103:177.
30. Poccia, F., Cipriani, B., Vendetti, S. et al. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonat phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J. Immunol. 159:6009.
31. Poccia, F., Battistini, L., Cipriani, B. et al. 1999. Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J. Infect. Dis. 180:858:
32. Levy, J. A., Mackewicz, C. E. and Barker, E. 1996. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17:217.
33. Cipriani, B., Borsellino, G., Poccia, F. et al. 2000. Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 95:39.
34. Wang, T., Scully, E., Yin, Z. et al. 2003. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 171:2524.
35. Goodbourn, S., Didcock, L. and Randall, R. E. 2000. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341.
36. Grandvaux, N., tenOever, B. R., Servant, M. J. and Hiscott, J. 2002. The interferon antiviral response: From viral invasion to evasion. Curr. Opin. Infect. Dis. 15:259.
37. Lechner, F., Wong, D. K., Dunbar, P. R. et al. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499.
38. Francavilla, V., Accapezzato, D., De Salvo, M. et al. 2004. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: Exploring the immunological mechanisms. Eur. J. Immunol. 34:427.
39. Cooper, S., Erickson, A. L., Adams, E. J. et al. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439.